V2 Capital’s Amgen AMGN Stock Holding History

V2 Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.33M	Buy	+8,324	New	+$1.31M	0.55%	45

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

V2 Capital's AMGN Position: Q1 2015 in Review

V2 Capital opened a new position in Amgen (AMGN) in Q1 2015: 8,324 shares worth $1.33M. The stake represents 0.55% of the portfolio and ranks #45 among its holdings.

1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

V2 Capital held 8,324 shares of Amgen worth $1.33M as of Q1 2015.
Amgen was a new V2 Capital position in Q1 2015.
Amgen made up 0.55% of V2 Capital's portfolio in Q1 2015, its #45 holding.
1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.